The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...

Randall K. Fields, the Chief Executive Officer of ReposiTrak, Inc. (NASDAQ:TRAK), recently sold 7,500 shares of the company's common stock. The transaction, which took place on January 21, 2025, was ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

Syndax Pharmaceuticals struggles with competitive pressures and market skepticism despite promising drugs and strong cash position. Read more on SNDX here.

Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entrée will result in any ...

A Nebraska lawmaker would like to see more regulations and physician follow-ups when it comes to chemically induced abortions ...

The U.S. Food and Drug Administration on Tuesday approved the first nasal spray that will help with treating major depressive ...

The agencies are charged with making decisions that touch the lives of every American and are the source of crucial ...

The Office of the Tennessee Attorney General announced a settlement Tuesday with Family Dollar Stores, a subsidiary of Dollar Tree Inc. This settlement follows an investigation that revealed Family ...

The Biden administration's eleventh-hour proposal to lower nicotine concentrations in cigarettes has led some Floridians to ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...